Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial

M Haude; R Erbel; P Erne; S Verheye; H Degen; P Vermeersch; N Weissman; F Prati; Nico Bruining; R Waksman; J Koolen

Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial

M Haude, R Erbel, P Erne, S Verheye, H Degen, P Vermeersch, N Weissman, F Prati, Nico Bruining, R Waksman, J Koolen

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

62 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	e160-e166
Journal	EuroIntervention
Volume	12
Issue number	2
Publication status	Published - 2016

Research programs

EMC COEUR-09

Cite this

Haude, M., Erbel, R., Erne, P., Verheye, S., Degen, H., Vermeersch, P., Weissman, N., Prati, F., Bruining, N., Waksman, R., & Koolen, J. (2016). Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial. EuroIntervention, 12(2), e160-e166.

@article{a89da16dc4ab486eb323baba10666229,

title = "Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial",

author = "M Haude and R Erbel and P Erne and S Verheye and H Degen and P Vermeersch and N Weissman and F Prati and Nico Bruining and R Waksman and J Koolen",

year = "2016",

language = "Undefined/Unknown",

volume = "12",

pages = "e160--e166",

journal = "EuroIntervention",

issn = "1774-024X",

publisher = "EuroPCR",

number = "2",

}

Haude, M, Erbel, R, Erne, P, Verheye, S, Degen, H, Vermeersch, P, Weissman, N, Prati, F, Bruining, N, Waksman, R & Koolen, J 2016, 'Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial', EuroIntervention, vol. 12, no. 2, pp. e160-e166.

Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial. / Haude, M; Erbel, R; Erne, P et al.
In: EuroIntervention, Vol. 12, No. 2, 2016, p. e160-e166.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Safety and Performance of the Drug-Eluting Absorbable Metal Scaffold (Dreams) in Patients with De Novo Coronary Lesions: 3-Year Results of the Prospective, Multicentre, Firstin-Man Biosolve-I Trial

AU - Haude, M

AU - Erbel, R

AU - Erne, P

AU - Verheye, S

AU - Degen, H

AU - Vermeersch, P

AU - Weissman, N

AU - Prati, F

AU - Bruining, Nico

AU - Waksman, R

AU - Koolen, J

PY - 2016

Y1 - 2016

M3 - Article

SN - 1774-024X

VL - 12

SP - e160-e166

JO - EuroIntervention

JF - EuroIntervention

IS - 2

ER -